Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Device
Medical Devices/Diagnostic Equipment

VITROS Chemistry Products OP Reagent Recalled for Inaccurate QC Results

Agency Publication Date: July 2, 2025
Share:
Sign in to monitor this recall

Summary

Ortho-Clinical Diagnostics is recalling approximately 2,017 units of VITROS Chemistry Products OP Reagent Gen 15 (Model 680 1997). This reagent is a laboratory tool used to detect opiates in urine. The recall was initiated because certain production lots may produce lower than expected quality control results, which could prevent laboratories from performing the required testing protocol and lead to delays in providing patient results.

Risk

If a laboratory is unable to achieve valid quality control results, they will be unable to run the diagnostic test. This creates a risk of delayed patient results for opiate detection, though no specific injuries have been reported.

What You Should Do

  1. This recall affects VITROS Chemistry Products OP Reagent Gen 15 (Model Number 680 1997) used for opiate detection in urine.
  2. Check your laboratory inventory for the following lot numbers: 1527-15-2749 (exp. 17-Nov-2025), 1527-15-2771 (exp. 17-Dec-2025), 1527-15-2818 (exp. 11-Apr-2026), or 1527-15-2871 (exp. 15-May-2026).
  3. Stop using the recalled product. Contact Ortho-Clinical Diagnostics or your distributor to arrange for a return, replacement, or correction of the affected packs.
  4. Call the FDA at 1-888-463-6332 for additional questions regarding medical device recalls.

Your Remedy Options

๐Ÿ“‹Other Action
How to: Stop using the recalled product. Contact the manufacturer or your distributor to arrange return, replacement, or correction.

Affected Products

Product: VITROS Chemistry Products OP Reagent Gen 15
Variants: Generation 15, 50 OP tests per pack
Model / REF:
680 1997
Lot Numbers:
1527-15-2749 (exp. 17-Nov-2025)
1527-15-2771 (exp. 17-Dec-2025)
1527-15-2818 (exp. 11-Apr-2026)
1527-15-2871 (exp. 15-May-2026)
UDI:
10758750001835

The VITROS OP Reagent is a dual-chambered package containing ready-to-use liquid reagents. One sales unit contains 6 Microtip packs.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 97034
Status: Active
Manufacturer: Ortho-Clinical Diagnostics, Inc.
Sold By: Clinical laboratories; Medical distributors
Manufactured In: United States
Units Affected: 2,017 units
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.